GLOW Blend

Profile · 01

Overview

GLOW is a multi-peptide blend combining GHK-Cu, TB-500 (Thymosin Beta-4 fragment), and BPC-157, designed to target tissue repair, skin rejuvenation, and anti-inflammatory support through complementary regenerative pathways. None of the individual components are FDA-approved for therapeutic use. Preclinical models demonstrate accelerated wound healing, collagen synthesis, and anti-inflammatory activity for each component, though human clinical data remain limited. This protocol presents a once-daily subcutaneous approach using a practical dilution for clear insulin-syringe measurements.

At a Glance

Goal

Accelerate tissue repair, support skin rejuvenation, and reduce inflammation

Protocol

Flat-dose daily protocol over a 4-week cycle with rest periods between cycles.

Typical daily range

2,330 mcg once daily (flat dose; no titration)

Start

2,330 mcg daily from Week 1

Target

2,330 mcg daily maintained through Week 4

Frequency

Once per day (subcutaneous)

Cycle Length

4 weeks on, 2–4 weeks off; repeat as needed

Timing

Any consistent time; rotate injection sites

Route

Subcutaneous

Cycle

4 weeks on, 2–4 weeks off

Inject once daily subcutaneously using a practical dilution. The blend leverages three complementary regenerative peptides with distinct but synergistic mechanisms. Dosing is based on preclinical models and community protocols; human clinical validation for this specific combination remains unavailable.

Dose progression

Weeks 1–4

2,330 mcg (2.33 mg)

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Profile · 03

Videos

Science · 01

How GLOW Blend works.

GLOW combines three peptides with distinct but complementary mechanisms of action. GHK-Cu is a naturally occurring copper tripeptide that functions as a genomic modulator, upregulating genes related to tissue growth and downregulating those linked to inflammation; it stimulates collagen and glycosaminoglycan synthesis, promotes angiogenesis, exhibits antioxidant properties, and suppresses NF-kB activity. TB-500 (Thymosin Beta-4 fragment) facilitates cell migration and cytoskeletal remodeling by binding to actin protein, promoting mobilization of cells to injury sites, accelerating angiogenesis, recruiting stem cells, and modulating immune response to limit excessive inflammation and fibrosis. BPC-157 enhances growth factor signaling by increasing receptors for VEGF and PDGF, upregulates nitric oxide pathways, lowers pro-inflammatory cytokines, promotes repair cell migration and survival, and activates the FAK-paxillin pathway in tendon cells. Together, these three peptides address wound repair, angiogenesis, collagen remodeling, and inflammation through distinct but synergistic pathways.

Science · 02

Effects

Observations from clinical or preclinical literature.

Accelerated wound healing through complementary tissue repair pathways (animal data for all three components)

Anti-inflammatory and pain reduction via NF-kB downregulation (GHK-Cu), cytokine suppression (TB-500), and tissue inflammation dampening (BPC-157)

Improved tissue quality and reduced fibrosis through organized collagen deposition and decreased myofibroblast accumulation

Multi-tissue regeneration applicable to orthopedic injuries (tendon, ligament, muscle), dermatologic uses (skin rejuvenation), and gastrointestinal repair

Generally well tolerated based on existing research; possible mild injection-site reactions (redness, itching)

Large-scale human clinical trials are still needed to confirm efficacy and safety for specific indications

Science · 03

Caution

Individuals with active cancer or a history of cancer should avoid use due to the pro-angiogenic properties of BPC-157 and GHK-Cu

Not recommended during pregnancy or breastfeeding (no safety data available for this blend)

Use with caution if taking anticoagulants or medications affecting blood clotting

Consult a healthcare provider before use if you have any chronic medical conditions

Individuals with copper metabolism disorders (e.g., Wilson's disease) should avoid GHK-Cu-containing blends

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Lifestyle · 01

CoFactors

Vitamin C

Essential cofactor for collagen synthesis; supports the regenerative actions of GHK-Cu and BPC-157.

Zinc

Supports wound healing and immune function; commonly depleted in tissue injury.

Copper

Critical for GHK-Cu function and collagen cross-linking; ensure adequate but not excessive intake.

Omega-3 fatty acids

Support anti-inflammatory pathways complementary to the blend's mechanisms.

Collagen Peptides

Provide substrate for tissue repair alongside the blend's collagen-stimulating actions.

Lifestyle · 02

Life Factors

Complementary strategies for best outcomes.

Maintain adequate protein intake (1.6–2.2 g/kg body weight daily) to support tissue regeneration

Implement progressive resistance training with appropriate activity modification to reinforce musculoskeletal adaptations

Prioritize sleep quality (7–9 hours nightly) to maximize natural healing processes

Manage stress through evidence-based techniques; chronic stress impairs healing

Stay well-hydrated and ensure adequate micronutrient intake, particularly vitamin C, zinc, and copper for collagen formation

Lifestyle · 03

Metrics

Day-to-day metrics worth tracking through the protocol.

Skin quality and wound healing progress — monitor changes in texture, elasticity, and healing rate of target areas
Pain levels and functional mobility — track changes in the target area to gauge healing response
Inflammation markers (subjective swelling, redness, heat) — track daily to identify trends
Sleep quality and recovery perception — poor sleep impairs healing; track to ensure adequate rest
Injection-site reactions — note any redness, swelling, or discomfort to guide site rotation

Lifestyle · 04

Labs

Baseline and periodic bloodwork to monitor systemic health during the protocol.

CRP (C-Reactive Protein)

General inflammation marker; track before and during protocol.

CBC (Complete Blood Count)

Monitor overall health and rule out underlying conditions.

CMP (Comprehensive Metabolic Panel)

Assess liver and kidney function during peptide use.

Copper and Ceruloplasmin levels

Monitor copper status given GHK-Cu component.

ESR (Erythrocyte Sedimentation Rate)

Secondary inflammation marker to corroborate CRP trends.

Calculators · 01

Supplies Calculator

Estimates assume the schedule defined for this peptide.

Length

Vial size

Bac. water

Syringe

Vials

0 × 70 mg each…

Syringes

Bac. water

0 mL

Swabs

02 per syringe

Calculators · 02

Dose Calculator

Vial

Bac. water

Syringe

Dose

Concentration

0mcg/mL

Volume per dose

0mL

…

Practice · 01

Preparation

Careful technique preserves potency. Solution should be clear — do not shake.

Allow vial to reach room temperature for 15–20 minutes before reconstitution.
Draw the chosen bacteriostatic water volume with a sterile syringe.
Inject slowly down vial wall; avoid foaming.
Gently swirl/roll until dissolved (do not shake).
Label with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
Use within 30 days; discard any unused solution after 30 days.

Practice · 02

Technique

General subcutaneous guidance from clinical best-practice resources.

Clean vial stopper and injection site with separate alcohol swabs; allow both to air-dry completely

Use insulin syringe (typically 29–31 gauge, 5/16 to 1/2 inch needle); draw calculated dose

Select site with adequate subcutaneous tissue (lower abdomen, thigh, upper arm); pinch a skinfold

Insert needle at 45° into the fatty subcutaneous tissue (90° acceptable with short needles into pinched fold)

Do not aspirate for subcutaneous injections; inject slowly and steadily over 2–3 seconds

Withdraw needle and apply gentle pressure with clean cotton swab (do not rub); rotate sites systematically with each injection

Discard used syringes immediately in sharps container; never reuse needles

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Practice · 03

Storage

Lyophilized

Store at room temp in dry, dark conditions; minimize moisture exposure.

Reconstituted

Refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles. Discard reconstituted vials after 30 days.

Notes

Allow vials to reach room temperature before opening to reduce condensation uptake.

Reference · 01

Notes

Use new sterile insulin syringes for each injection; dispose in sharps container

Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation

Inject slowly over 2–3 seconds; wait a few seconds before withdrawing the needle

Document daily dose, time, and site rotation to maintain consistency

Human clinical data for this specific blend are unavailable; clinical decisions should involve qualified healthcare providers

Reference · 02

References

International Journal of Molecular Sciences (2018)
Pickart L et al., "GHK-Cu regenerative and protective actions relevant to skin and connective tissue".
https://www.mdpi.com/1422-0067/19/7/1987
International Journal of Medical Sciences (2025)
"Tripeptides in wound healing and skin regeneration".
https://www.medsci.org/
Vitamins & Hormones/PubMed (2016)
Goldstein AL et al., "Thymosin Beta-4: a multi-functional regenerative peptide in dermal healing".
https://pubmed.ncbi.nlm.nih.gov/
Expert Opinion on Biological Therapy/PubMed (2012)
Crockford D, "Thymosin Beta-4: properties and applications in tissue repair".
https://pubmed.ncbi.nlm.nih.gov/
HSS Journal/PMC (2025)
Vasireddi N et al., "Emerging use of BPC-157 in orthopaedic sports medicine: systematic review".
https://pmc.ncbi.nlm.nih.gov/
Journal of Applied Physiology/PubMed (2011)
Chang CH et al., "BPC-157 tendon healing mechanisms".
https://pubmed.ncbi.nlm.nih.gov/
Immunize.org/IAC (2025)
"Subcutaneous injection administration guidance".
https://www.immunize.org/
Bachem Peptide Technical Guide (2023)
"Peptide handling, reconstitution, and storage best practices".
https://www.bachem.com/
CDC Pink Book, 14th Edition (2022)
"Vaccine administration: subcutaneous route guidelines".
https://www.cdc.gov/vaccines/pubs/pinkbook/